SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-20-005499
Filing Date
2020-03-11
Accepted
2020-03-11 16:41:48
Documents
87
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1862991
2 EXHIBIT 4.7 ex4_7.htm EX-4.7 18195
3 EXHIBIT 10.14 ex10_14.htm EX-10.14 153152
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 2767
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 13649
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 13787
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 6500
8 EXHIBIT 32.2 ex32_2.htm EX-32.2 6507
15 image02.jpg GRAPHIC 71974
16 image00005.jpg GRAPHIC 39772
  Complete submission text file 0001140361-20-005499.txt   7792346

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aqst-20191231.xml EX-101.INS 1102354
10 XBRL TAXONOMY EXTENSION SCHEMA aqst-20191231.xsd EX-101.SCH 66058
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqst-20191231_cal.xml EX-101.CAL 68978
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqst-20191231_def.xml EX-101.DEF 327667
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20191231_lab.xml EX-101.LAB 919355
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20191231_pre.xml EX-101.PRE 507154
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38599 | Film No.: 20705801
SIC: 2834 Pharmaceutical Preparations